Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
about
Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations.Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy.Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, MasDevelopmental Biology and Regenerative Medicine: Addressing the Vexing Problem of Persistent Muscle Atrophy in the Chronically Torn Human Rotator CuffDefective homocysteine metabolism: potential implications for skeletal muscle malfunctionComparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal MusclesThe complex of PAMAM-OH dendrimer with Angiotensin (1-7) prevented the disuse-induced skeletal muscle atrophy in mice.Therapeutic approaches to skeletal muscle repair and healing.Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.Renin-angiotensin system: an old player with novel functions in skeletal muscle.Drug Discovery of Therapies for Duchenne Muscular Dystrophy.A healthy tension in translational research.Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis.Understanding the process of fibrosis in Duchenne muscular dystrophy.High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis.Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular DystrophyThe Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.Connective tissue growth factor dependent collagen gene expression induced by MAS agonist AR234960 in human cardiac fibroblasts.CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD).Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors.The pro-fibrotic connective tissue growth factor (CTGF/CCN2) correlates with the number of necrotic-regenerative foci in dystrophic muscle.Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy.The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.Expression of the Mas receptor is upregulated in skeletal muscle wasting.Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
P2860
Q33962042-6ADBF5DD-9C53-4BBB-8432-2A385CD58294Q35749354-A9B49B44-FABD-43FF-ADFF-5B8FEC32A5C7Q36817631-EE9CCF7C-EB1C-497F-89C7-228229F8C9ACQ36856035-F76168A3-8200-48A5-A325-729F7311E4F7Q36875163-C4883761-DDA4-4D8E-95ED-4D3E5A6A3EC3Q37092032-12E00988-FB7C-4CFB-B15C-90E081680560Q37589749-E8C54F0B-E580-45CD-A3BF-331F1FE689EAQ37589790-E8B5FEDD-3B18-4BE1-9927-6EECCC1AF435Q37709770-9E6891A8-B601-45DF-9DBD-78140E313BECQ38225126-3F5B79EB-6C2F-40D7-806E-FF23E42766E5Q38258015-841F634A-A417-47CF-9FF5-60ACA494BE75Q38375202-6B81CE9C-B5E9-4C42-A1DC-2043FC6ABE2EQ38480698-218EE300-C882-4491-9F81-0495AD4E58BFQ38592372-093822E3-8DB5-4DB4-AA40-0E257D7ABEF6Q38956473-276A3769-B241-4EB7-9F87-60BBCA9B6608Q39342422-17D5659D-4A37-47D7-8290-C02AD7AD7523Q39629598-7E9CDE65-35AF-426D-A833-80D0983104C2Q39699112-BDB7ED0D-9FC2-40F4-A0D2-0C0E797608CFQ41479479-51DC3197-DD8D-4033-B1BD-170A406EACFEQ42836794-5E6578EC-2C0F-491A-A755-D2DF293EAA66Q46924901-14586A10-6ECA-471C-8E2E-50A5804033F5Q47234073-D29C51D7-6310-4D7B-9B2A-8ED5A76C699CQ47616685-6A9EE646-AE16-47D1-A4F6-1C375378F610Q47776900-BD344F1D-510F-4FAF-9D43-AB7FD4E4FD48Q48100107-9A26DD65-2E5F-419A-A93F-72332AE6C312Q49918232-C7E9FA4C-2B4E-4FD0-B1BF-12DBBC80CA1DQ52564618-8A41C2BE-4545-40AC-BCED-BF1FD6C2E812Q54189352-BD4C64D3-1825-48FB-8116-756D7518EF26Q54192199-697D1618-61CF-4F41-B6D7-E898B43E32CFQ54979072-5D38E6B4-A106-48E9-A3DC-D19511F4BDF1
P2860
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Inhibition of the angiotensin- ...... ue growth factor (CTGF/CCN-2).
@en
Inhibition of the angiotensin- ...... onnective tissue growth factor
@nl
type
label
Inhibition of the angiotensin- ...... ue growth factor (CTGF/CCN-2).
@en
Inhibition of the angiotensin- ...... onnective tissue growth factor
@nl
prefLabel
Inhibition of the angiotensin- ...... ue growth factor (CTGF/CCN-2).
@en
Inhibition of the angiotensin- ...... onnective tissue growth factor
@nl
P2093
P2860
P1476
Inhibition of the angiotensin- ...... ue growth factor (CTGF/CCN-2).
@en
P2093
Carlos Céspedes
Claudio Cabello-Verrugio
Daniel Cabrera
María Gabriela Morales
Yaneisi Vazquez
P2860
P2888
P304
P356
10.1007/S00441-013-1642-6
P577
2013-05-15T00:00:00Z